Novavax Offers U.S. a Fourth Strong Covid-19 Vaccine

admin June 14, 2021
The company’s large U.S. trial found an efficacy rate of about 90 percent. But at this point, the nation is awash in other shots.

source https://www.nytimes.com/2021/06/14/health/covid-vaccine-novavax.html

Post a Comment

0 Comments